InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the complete record of transactions filed by Maricich Yuri, Directeur Médical. Officer active across 2 companies, notably Pear Therapeutics, Inc.. Cumulatively, 5 filings have been logged. Breakdown: 2 buys · 1 sell. Total volume traded: €31k. Activity tracked since 14 January 2023. The latest transaction was filed on 3 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Yuri Maricich serves as Chief Medical Officer of Pear Therapeutics, Inc. In this role, he is responsible for leading the company's medical and clinical activities. Yuri plays a key role in developing new treatments and guiding strategic medical decisions. His expertise in medicine and research is essential for the success of Pear Therapeutics.